NEPH Nephros Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NEPH

Price (delayed)

$2.05

Market cap

$21.61M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.15

Enterprise value

$19.14M

Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA. Its diverse team of passionate employees are dedicated to advancing ...

Highlights
The EPS has soared by 79% YoY and by 17% from the previous quarter
Nephros's net income has soared by 79% YoY and by 14% from the previous quarter
Nephros's equity has increased by 49% YoY but it has decreased by 3.1% QoQ
The company's debt has surged by 135% QoQ and by 68% YoY
The company's quick ratio fell by 21% YoY and by 17% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.nephros.com
Peers: RMTI BSX TMO DHR

Key stats

What are the main financial stats of NEPH
Market
Shares outstanding
10.54M
Market cap
$21.61M
Enterprise value
$19.14M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.57
Price to sales (P/S)
1.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.34
Earnings
Revenue
$14.24M
EBIT
-$1.57M
EBITDA
-$1.36M
Free cash flow
$752,000
Per share
EPS
-$0.15
Free cash flow per share
$0.07
Book value per share
$0.8
Revenue per share
$1.37
TBVPS
$1.01
Balance sheet
Total assets
$11.86M
Total liabilities
$3.5M
Debt
$1.84M
Equity
$8.36M
Working capital
$6.29M
Liquidity
Debt to equity
0.22
Current ratio
3.98
Quick ratio
2.75
Net debt/EBITDA
1.82
Margins
EBITDA margin
-9.5%
Gross margin
59%
Net margin
-11.1%
Operating margin
-11.2%
Efficiency
Return on assets
-14.3%
Return on equity
-18.2%
Return on invested capital
-32.7%
Return on capital employed
-16.1%
Return on sales
-11%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NEPH stock price

How has the Nephros stock price performed over time
Intraday
3.02%
1 week
1.99%
1 month
-2.84%
1 year
46.41%
YTD
-40.75%
QTD
-6.39%

Financial performance

How have Nephros's revenue and profit performed over time
Revenue
$14.24M
Gross profit
$8.41M
Operating income
-$1.59M
Net income
-$1.58M
Gross margin
59%
Net margin
-11.1%
The company's net margin has surged by 85% YoY and by 18% QoQ
Nephros's net income has soared by 79% YoY and by 14% from the previous quarter
The gross profit has surged by 78% year-on-year and by 6% since the previous quarter
The operating margin has soared by 74% YoY and by 7% QoQ

Growth

What is Nephros's growth rate over time

Valuation

What is Nephros stock price valuation
P/E
N/A
P/B
2.57
P/S
1.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.34
The EPS has soared by 79% YoY and by 17% from the previous quarter
NEPH's price to book (P/B) is 58% less than its 5-year quarterly average of 5.9 but 9% more than its last 4 quarters average of 2.3
Nephros's equity has increased by 49% YoY but it has decreased by 3.1% QoQ
The price to sales (P/S) is 71% lower than the 5-year quarterly average of 5.0 and 3.3% lower than the last 4 quarters average of 1.5
The revenue has grown by 43% YoY and by 5% from the previous quarter

Efficiency

How efficient is Nephros business performance
The ROS has soared by 85% YoY and by 19% from the previous quarter
The ROE has soared by 81% YoY and by 22% from the previous quarter
Nephros's ROIC has soared by 74% YoY and by 16% from the previous quarter
The return on assets has surged by 74% year-on-year and by 16% since the previous quarter

Dividends

What is NEPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NEPH.

Financial health

How did Nephros financials performed over time
The total liabilities has soared by 65% YoY and by 53% QoQ
The current ratio has decreased by 32% YoY and by 14% QoQ
The company's debt is 78% lower than its equity
The debt to equity has surged by 144% since the previous quarter and by 10% year-on-year
The company's debt has surged by 135% QoQ and by 68% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.